Home > Press > Applied Nanoscience Announces Test Results, NanoMask Progress and Merger Update
Abstract:
Applied Nanoscience Inc. (ANI) (PINKSHEETS: APNN) today announced that it has received highly successful results in a recent expansion phase of testing against its proprietary silver NanoFense™ Technology. Treated filter samples, which had been subjected to a process which simulated aging for one year, were challenged with new virus and bacteria in an effort to demonstrate the broadened capabilities of the company's Nanoparticle - Enhanced - Filtration - Technology platform (NEFT). When the coated filter samples were exposed to the Influenza A virus, a 4.25 log reduction was achieved; equivalent to eradication of more than 99.99% of the virus.
Bacterial challenge results included a 3.38 average log reduction ( > 99.9%) against Haemophilus Influenzae (H-flu) and a 3.10 average log reduction ( > 99.9%) against Staphylococcus aureus. Filter media treated with the proprietary formulation which underwent the accelerated one year aging process has now proven successful against five different and dangerous pathogens.
"Armed with these results, we will immediately begin discussions with potential license partners in a number of major consumer markets, apart from the environmental mask market," said Thomas K. Allen, President and CEO, ANI.
Separately, Applied Nanoscience reports that its potential merger partner, Emergency Filtration Products, Inc. (EFP) has informed ANI that it is making substantial progress towards filing a new 510(k) premarket notification for its NanoMask with the Food and Drug Administration (FDA). ANI intends to supply their proprietary nanoparticle formulation to EFP which use it to coat the NanoMask filter.
According to EFP, it has begun discussions with a number of international distributors and potential customers to whom it could export product from Mexico in advance of receiving clearance from the FDA to sell and manufacture the NanoMask domestically. Although it will take time and capital to re-establish manufacturing operations in Mexico, EFP reports that it could begin manufacturing the NanoMask in Mexico and begin selling the NanoMask to international customers without endangering its 510 (k) premarket notification to the FDA.
On the merger front, ANI and EFP continue to work towards entering a definitive merger agreement along the terms previously announced. The two companies do not expect to enter a definitive agreement until EFP successfully updates all of its filings with the Securities and Exchange Commission (SEC). Updating EFP's SEC filings, completion of due diligence and preparing the documents and filings necessary to consummate the merger will require significant financial commitments from both companies.
####
About Applied Nanoscience Inc.
Applied Nanoscience Inc. is a marketer and developer of innovative, high-performance filtration products, systems and technologies to customers worldwide in a focused effort to provide a safer tomorrow.
Safe Harbor Statement
This release may contain statements that are forward looking. Such statements are made based upon current expectations that are subject to risk and uncertainty. ANI does not undertake to update forward-looking statements in this news release to reflect actual results of and changes in assumptions or changes in other factors affecting such forward-looking information. The actual future plans and results of the companies could differ significantly from such forward-looking statements.
For more information, please click here
Contacts:
Philippe Niemetz
PAN Consultants Ltd.
800-477-7570
or
212-344-6464
Investor Relations
Copyright © Marketwire
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
Acquisitions/Mergers/Splits
180 Degree Capital Corp. Life Science Portfolio Company Enters Into Definitive Agreement to be Acquired May 6th, 2020
180 Degree Capital Corp.’s Portfolio Company, Synacor, Inc., Agrees to Merge with Qumu Corporation in All-Stock Transaction February 11th, 2020
Combination of Nanometrics and Rudolph Technologies to Create Onto Innovation October 16th, 2019
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||